IL6 and chronic obstructive pulmonary disease: Both serum IL-6 and 25(OH)D level markers reached statistical significance in separating patients with advanced-stage COPD (GOLD 4) from earlier disease stages (COPD 1–3), showing moderate sensitivity but moderate-to-high specificity (Table 3).